Objective: Insulin resistance and type 2 diabetes mellitus (T2DM) are associated with increased adipocyte size, altered secretory pattern and decreased differentiation of preadipocytes. In this study, we identified the underlying molecular processes in preadipocytes of T2DM patients, a characteristic for the development of T2DM. Design and Participants: Preadipocyte cell cultures were prepared from subcutaneous fat biopsies of seven T2DM patients (age 53±12 years; body mass index (BMI) 34±5 kg m -2 ) and nine control subjects (age 51±12 years; BMI 30±3 kg m -2 ). Microarray analysis was used to identify altered processes between the T2DM and control preadipocytes. Results: Gene expression profiling showed changed expression of transcription regulators involved in adipogenesis and in extracellular matrix remodeling, actin cytoskeleton and integrin signaling genes, which indicated decreased capacity to differentiate. Additionally, genes involved in insulin signaling and lipid metabolism were downregulated, and inflammation/ apoptosis was upregulated in T2DM preadipocytes. Conclusion: Decreased expression of genes involved in differentiation can provide a molecular basis for the reduced adipogenesis of preadipocytes of T2DM subjects, leading to reduced formation of adipocytes in subcutaneous fat depots, and ultimately leading to ectopic fat storage.
Introduction
Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia, impaired insulin secretion from pancreatic b-cells and insulin resistance in peripheral tissues, including metabolically important tissues like liver, skeletal muscle and adipose tissue. 1 Over the past 10 years, the incidence of T2DM has increased dramatically with an expected rise to B300 million patients worldwide in 2025. 2, 3 The development of T2DM is generally preceded by obesity, as 80% of the patients are obese (body mass index (BMI) 430 kg m -2 ), which also increases the risk of other obesityassociated metabolic diseases like cardiovascular diseases. 4, 5 Adipose tissue was once thought to be an inert energy storage depot, but it is now known as a critical endocrine organ, as it also secretes a range of peptides, hormones and other signaling molecules that have a role in a large number of diverse processes like glucose and lipid homeostasis. [6] [7] [8] Changes in the secretory pattern of adipocytes are observed in obesity, T2DM and cardiovascular diseases. 9 Adipose tissue is composed of various subcutaneous and visceral depots throughout the body, and is composed of mature energy-storing adipocytes, adipocyte precursor cells called preadipocytes and stromal vascular cells. 10 Enlarged adipocytes are found in patients with T2DM and prediabetic individuals and appear to be an independent marker of insulin resistance in prediabetic subcutaneous adipose tissue. 11 Gene expression analysis of adipocytes and adipose tissue of patients with insulin resistance has revealed a reduced expression of adipose tissue-specific proteins and of adipogenic transcription regulators like PPAR-g (peroxisome proliferator-activated receptor-g), C/EBPs (CCAAT/ enhancer-binding proteins) and SREBPs (sterol regulatory element-binding proteins). 12 In addition, adipose tissue inflammation in obese and insulin-resistant individuals impairs the differentiation of preadipocytes and reduces the oxidative capacity of visceral adipose tissue. [13] [14] [15] So far, most of the gene expression studies have focused on the role of adipocytes in the development of T2DM, and preadipocyte gene expression analyses were mainly used to study obesity. 12, 13, 16 Our study is the first to perform global gene expression profiling of preadipocytes of T2DM patients. We aim to identify the processes in preadipocytes of T2DM patients and nondiabetic age-and BMI-matched controls that are a characteristic of T2DM.
Subjects and methods

Subjects
Our study subjects were seven patients with T2DM and nine normoglycemic controls within the same age and BMI range as the T2DM subjects (Table 1) . Lipid-lowering medication was stopped 2 weeks before biopsy, and three of seven T2DM subjects continued insulin treatment, one T2DM subject continued with metformin treatment and three T2DM subjects did not use glucose-lowering medication. T2DM and controls were recruited through the Lipid Clinic of the Maastricht University Medical Center (MUMC). The Human Investigation Review Committee of the MUMC approved the study protocol, and all subjects gave written informed consent.
Preadipocyte isolation and culture
In a fasted state, subcutaneous adipose tissue biopsy samples were taken caudally from the umbilicus by liposuction under local anesthesia and subsequently treated with collagenase. 17 The cell suspension was filtered through 500 mm nylon mesh and spun at 220 g for 1 min to separate preadipocytes from mature adipocytes. Preadipocytes were suspended in 5 ml Dulbecco's modied Eagle's medium containing 10% fetal calf serum (Gibco-Invitrogen, Carlsbad, CA, USA) and 1% glutamax/penecillin/streptomycin (Gibco-Invitrogen), grown for two passages and frozen. Control and T2DM preadipocytes were taken into culture in parallel and cultured for three passages till a 90% confluent 162 cm 2 culture flask was obtained per sample (passages 5-9) for RNA isolation.
Microarray procedure
Total RNA was isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and purified with the RNeasy clean-up kit (Qiagen, Valencia, CA, USA), according to the manufacturers' protocol. RNA quantity and purity were determined spectrophotometrically using the Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE, USA). RNA (1 mg) from each sample with a RNA integrity number 47 (Bioanalyser 2100; Agilent, Santa Clara, CA, USA) was amplified using the Amino-Allyl (AA) MessageAmp II antisense RNA (aRNA) kit (Ambion, Austin, TX, USA) to generate AA-aRNA. AA-aRNA was generated according to the manufacturer's protocol with a modification in the ratio of UTP:AA-UTP, which was changed from 1:1 to 7:3. RNA integrity was assessed by determining the aRNA size. Each amino AA-aRNA sample was coupled to Cy3 or Cy5 (Amersham Biosciences, GE Healthcare, Little Chalfont, UK) and purified with the RNeasy Minelute clean-up kit (Qiagen). RNA quantity and dye incorporation were determined spectrophotometrically using the Nanodrop. Hybridization was performed using the Operon Human oligo collection V2 (21 521 features) spotted on CodeLink slides (Amersham Biosciences) printed by the Microarray Facility (University Medical Center Utrecht, The Netherlands). T2DM patients and controls were paired on each slide based on, respectively, sex, age and BMI. Two-color microarray hybridizations were performed including dye swap for technical replication. Hybridizations, washings and slide drying were performed on a Tecan HS4800 hybridization station (Tecan, Mannedorf, Switzerland). Slides were blocked in 5 Â saline-sodium citrate (SSC), 25% formamide, 0.1% sodium dodecyl sulfate (SDS) and 1% bovine serum albumin (Sigma, St Louis, MO, USA) for 1 h. A total of 120 pmol of each dye-labeled aRNA sample (2-4.5% dye incorporation) was fragmented using RNA fragmentation buffer (Ambion), mixed with 100 mg transfer RNA (Roche, Mannheim, Germany) and 50 mg Herring sperm DNA (Invitrogen) in 120 ml hybridization solution (5 Â SSC 25% formamide, and 0.1% SDS), denaturated for 5 min at 95 1C, hybridized for 16 h at 42 1C and washed three times with decreasing concentrations of SSC and SDS (1 Â SSC, 0.2% SDS; 0.1 Â SSC, 0.2% SDS; 0.1 Â SSC). Array scanning was performed on an Axon 4000B scanner (Axon, Sunnyvale, CA, USA) with laser power 100% for both channels and three photo multiplier settings for Microarray data statistical analysis First, each gene was analyzed using a regression model. 18 The Akaike's information criterion (AIC) was used to identify the differently expressed genes. Then, these are mapped to processes, which are ranked by their z-scores and permute P-values. Bad and missing spots were not included in the analysis. Second, the scanning power with the least missing and most values above background for each gene were kept. If more than one scan setting was suitable for a spot, then the scanning at medium power was preferred over high power, which was itself preferred over the low setting. Scanning settings for each gene was constant between arrays.
A more detailed description of this analysis is shown in the Electronic Supplementary Material (ESM 5). Briefly, the foreground intensities of the remaining genes were analyzed using a multivariate Gaussian linear regression including labeling efficiency, dye swap, hybridization days, background level, sex, age, BMI and a random effect to take into account multiple observations on the same subject. The inference criterion used for comparing the models is their ability to predict the observed data, that is, models are compared directly through their minimized minus log-likelihood. When the numbers of parameters in models differ, they are penalized by adding the number of estimated parameters, a form of the AIC. 19 For each gene, the group was then added to the model. The gene under consideration was found to be differentially expressed if the AIC was smaller when compared with the AIC of the model not containing the group effect.
The genes and their fold changes were loaded into the Gene Map Annotator (GenMAPP, version 2.0) 20 and Pathway
Profiler (MAPPFinder) 21 to evaluate the transcripts in relation to known biological processes, molecular function and cellular component based on gene ontology terms 22 and local maps. Gene database Hs-std_20060526 and MAPPs version Hs_contributed_20070308 were used to obtain a ranked list of pathways with differentially expressed genes. MappFinder software was used to select the MAPPs with relatively high numbers of differentially expressed genes. The ranking of regulated pathways was indicated by the individual Z-scores. The Z-score increased when higher numbers of changing genes were found, taking into account the number of genes present in the MAPP that were represented on the array, and the total number of genes involved in the concerning MAPP. MAPPs were selected for further study if the Z-score was 41.96.
Real-time quantitative PCR validation
Differentially expressed genes were validated by real-time quantitative PCR (qPCR) on the same RNA samples, as used for the microarrays. Primers were designed using Primer Express software version 3.0 (Applied Biosystems, Carlsbad, CA, USA) (sequences primers, see ESM, Table 4 ). Complementary DNA was synthesized using Superscript II complementary DNA synthesis kit (Invitrogen). Quantification was carried out using Bio-Rad MyiQ Single-Color Real-Time PCR detection system (Bio-Rad, Veenendaal, The Netherlands) using qPCR Mastermix Plus for SYBR Green I (Eurogentec, Seraing, Belgium). The cycling conditions were: an initial step for 2 min at 50 1C, activation of the enzyme at 95 1C for 10 min and 40 cycles of 15 sec at 95 1C followed by 1 min at 60 1C. The mRNA levels of each gene were normalized to those of the housekeeping gene encoding TATA-box binding protein (TBP), which was invariable between the preadipocyte samples. For best comparison, results were analyzed using Gaussian linear regression, similar to the microarray analysis. The housekeeping gene, age, sex and BMI were included in the analysis. The AIC was used to assess whether there was a difference between the controls and T2DM subjects (group effect). All statistical analyses presented were performed using the freely available program R 23 and the publicly available library 'growth'.
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CPT1 activity assay Carnitine palmitoyltransferase 1 (CPT1) activity was measured in preadipocytes by tandem mass spectrometry as published by van Vlies et al. 25 except that digitonin was used in a concentration of 20 mg ml -1 at a final protein concentration of 0.3 mg ml -1
.
Preadipocyte differentiation
The human preadipocyte cell line from a patient with SGBS (Simpson-Golabi-Behmel syndrome), which has a high capacity for adipose differentiation, was used to explore the CPT1a and CPT1b expression pattern during preadipocyte differentiation. SGBS preadipocytes were differentiated according to the protocol as published by Wabitsch et al.
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Results
Validated microarray gene expression data
Microarray analysis was performed on RNA from preadipocyte cultures of seven T2DM and nine control subjects (Table 1) , comparable in age, BMI and waist-to-hip ratio. T2DM subjects had elevated insulin and glucose levels, whereas control subjects were normoglycemic. Cholesterol and triglyceride levels were higher in the T2DM subjects. Purity of the culture and infiltration of other cell types like fibroblasts was checked under a light microscope and by monitoring expression of macrophage, endothelial cell and
Intrinsic gene expression changed in T2DM preadipocytes FHJ van Tienen et al stem cell-specific genes. No differences were found between the T2DM and control group for endothelial cell or stem cellspecific genes, and only 1 of 46 macrophage-specific genes was differentially expressed, namely cytochrome b-245 (ESM, Table 2 ).
To assess the consistency of the microarrays, 12 probes were spotted 17 times on each array and analyzed individually. Of the 12 probes, 11 gave a signal above detection level with a consistent fold change. All replicates of three probes were decreased (fold change o0.90), of one probe increased (fold change 41.10) and expression of the replicates from the other seven probes were unchanged between T2DM patients and controls. The decreased expression of one of the probes spotted multiple times, namely GAPDH (glyceraldehyde 3-phosphate dehydrogenase), was also verified by qPCR. Expression data from both platforms were analyzed in a similar manner (Figure 2 ). In all, 20 significantly altered genes on the microarray were changed in the same direction using qPCR, which was significant for 13 genes. The seven remaining genes were significantly changed on the microarray, but had a confidence interval including one with qPCR analysis, although their means pointed toward changes in the same direction. The correlation of the 20 genes analyzed on both platforms was 0.82, with Po0.01 (data not shown).
Genes differentially expressed in T2DM preadipocytes
Using two-color microarrays, 21 337 transcripts were analyzed, and 8678 of those had signal intensity higher than twice the background intensity. Normal linear regression modeling indicated that 1144 transcripts were differentially expressed with a fold change of minimal 10%, of which 431 transcripts were increased and 713 transcripts were decreased in the T2DM preadipocytes (ESM, Table 1 and Figure 1 ). Fold changes were in general small; 39 of the 713 decreased transcripts (5.5%) had a fold change o0.5, and the most extreme reduced probe had a fold change of 0.29. Of the 431 increased transcripts in the T2DM group, only eight transcripts (1.9%) were more than two times higher with a maximum of 2.98.
Process-based analysis of differentially expressed genes
We used a process-based approach to identify differentially expressed pathways between preadipocytes from T2DM and control subjects. The 886 differently expressed genes that could be annotated were used for gene ontology-based analysis using the GenMAPP/MAPPFinder program (ESM, Table 3 ). In all, 13 pathways (Table 2) were found significantly changed with MAPPFinder analysis with a z-score of 41.96, and permute P-value of o0.10. The most significantly changed local pathways or gene groups comprised adipogenesis, alanine and aspartate metabolism, glycerolipid metabolism, insulin signaling, ribosomal proteins, androgen receptor signaling and focal cell adhesion. In addition, 38 gene ontology biological process terms were significantly changed with a Z-score of 41.96 and a minimum of three changed genes per term (Table 3) . Detailed information about the function of differently expressed genes was obtained using Entrez Gene, OMIM (Online Mendelian Inheritance in Man) and Pubmed to complete the altered processes represented in GenMAPP.
Differentially expressed processes: adipogenesis, insulin signaling, lipid metabolism and inflammation and apoptosis Pathways comprising genes involved in the adipogenesis process, MAPK (mitogen-activated protein kinase) signaling Intrinsic gene expression changed in T2DM preadipocytes FHJ van Tienen et al pathway, focal adhesion pathway and insulin signaling, were among the most pronounced pathways in the GenMAPP/ MAPPFinder analysis (Table 2) . Genes involved in these pathways (Table 4) are mainly decreased. Insulin signaling pathway shows reduced insulin receptor substrate regulation, MEK/MAP kinase activation and modulators of insulin signaling. Also, lipid metabolisms, including genes involved in lipid b-oxidation, biosynthesis and lipolysis, were decreased in T2DM preadipocytes. The hormone-sensitive lipolysis (HSL) process was not clearly represented in GenMAPP, but using literature search of significantly changed genes we identified changes in key regulators of cAMP-dependent protein kinase induction of HSL, like ADRA2A (adrenergic, a-2A, receptor) and PKA (protein kinase A), leading to reduced HSL. Although preadipocytes are metabolically not very active, the key gene for the import of long chain fatty acids into mitochondria and b-oxidation, CPT1, was severely decreased. The fold change of the T2DM preadipocytes ± confidence interval (CI) of each gene on both platforms is shown. *Genes that are significantly changed on both platforms. Abbreviations: GO, Gene Ontology; JNK, c-Jun N-terminal kinase; MAPKKK, mitogen-activated protein kinase kinase kinase; NLS, nuclear-localization signal. GO terms biological process with Z-score 41.96, Po0.10 and number changed X3 were considered to be significantly changed. ). To explore the expression pattern of CPT1a and CPT1b during adipogenesis, preadipocytes were differentiated to adipocytes. As human preadipocytes generally have low differentiation capacity, a preadipocyte cell line derived from a patient with SGBS with a high differentiation capacity and a gene expression pattern that is similar to differentiating preadipocytes from healthy subjects 26 was cultured and differentiated according to the protocol. Expression of CPT1a and CPT1b was analyzed by qPCR analysis (Figure 2a) , and TBP was used for normalization. On the first day after induction of adipogenesis, CPT1a expression increases and is the predominant form. From days 2 to 4, CPT1a decreases again, whereas CPT1b expression goes up after induction until day 4. After day 4, the expression of both genes stabilizes at a more or less equal level. FABP4 (fatty acid binding protein 4), which is a marker for adipogenesis, was used to analyze differentiation progression, and FABP4 expression rises drastically during differentiation (Figure 2b) . Genmapp/Mappfinder analysis ( Table 2) further identified the local map Complement and Coagulation cascade, and gene ontology terms (Table 3 ) regulation of programmed cell death, regulation of apoptosis and caspase regulator activity to be significantly overrepresented, indicating stimulation of the process.
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Discussion
Gene expression profiling of cultured preadipocytes from T2DM and a control group was performed to identify altered molecular processes related to T2DM. Before analyzing the gene expression data in full detail, we first checked the consistency of our results and the homogeneity of the preadipocyte cultures. Microarray data were validated by qPCR analysis of 20 genes that were significantly changed on the microarray platform ( Figure 1 ). All transcripts validated Intrinsic gene expression changed in T2DM preadipocytes FHJ van Tienen et al by qPCR analysis showed a fold change in the same direction on both platforms, although this was nonsignificant for 7 out of the 20 genes. Analyses of microarray and qPCR data were performed in a similar way, but differences between the platforms, for example, probe location, dye swap, normalization and relative small fold changes (fold change o2), might explain why part of the qPCR results did not reach the same level of significance. The correlation between the microarray data and qPCR data was 0.82 (Po0.01), indicating that the obtained microarray data are accurate and valid. 27 From checking the preadipocyte cultures visually and by analyzing cell type-specific gene expression (ESM, Table 2 ), we concluded that the results were derived from preadipocyte-specific gene expression without significant contributions of macrophage, stem cell or endothelial cell infiltration. This allows identifying intrinsic alterations in molecular mechanisms by excluding the environmental influence. Culturing did not influence the ability to detect altered gene expression related to the diseased state. 13, 28 Additionally, wash-out of medication, for example metformin, is expected during culture, as it acts for only 8-12 h and adipose tissue is not the primary target. Therefore, we do not expect that metformin therapy influences our data. Insulin was used by three T2DM patients, but the insulin and glucose levels were comparable with T2DM subjects withdrawn from therapy. We conclude that our study reflects reliable gene expression differences between preadipocytes from T2DM and controls.
Differentiation capacity of T2DM preadipocytes
We observed a general decrement of genes involved in transcription regulation of the adipogenesis process, including insulin signaling, transcription regulation and extracellular matrix (ECM) and cytoskeleton remodeling in T2DM preadipocytes ( Figure 3) . Transcription activation by insulin/ insulin growth factor (IGF) signaling is one of the first events upon induction of differentiation, and IRS1 (insulin receptor substrate 1) and IGF1, which are the stimulators of this process, are decreased in T2DM preadipocytes. IGF1 reduction results in decreased expression of downstream MAPKs and transcription factor KLF6 (Kruppel-like factor 6), which is induced by IGF1 and inhibits DLK1 (d-like kinase 1), and decrement of KLF6 expression inhibits adipogenesis. 29, 30 The fact that the expression of IGFR1 and DLK1 is not changed may imply that these proteins are under post-translational control. Preadipocytes from T2DM preadipocytes have increased expression of TWIST2, which interacts with SREBP1 and thereby inhibits transcriptional activity of SREBP1. Overexpression of TWIST2 may inhibit processes activated by SREBP1, a key transcription factor in lipogenesis and insulin-dependent gene expression during adipogenesis.
In contrast, C/EBPd and its downstream target KLF5 are stimulators of adipogenesis that are increased in T2DM preadipocytes. 31, 32 Although C/EBPd is a downstream target of SREBP, upon insulin stimulation, 82% of the effect is achieved via C/EBPb, which is expressed during adipogenesis. 33 C/EBPd has also been implicated in inflammation, and can be activated by, for example, tumor necrosis factora, interferon-g and interleukins 1 and 6. 34 Increased C/EBPd expression may therefore be related to inflammation rather than insulin-stimulated differentiation. In addition, preadipocytes of T2DM subjects have increased expression of inhibitors of adipogenesis, like IL6ST (interleukin 6 signal transducer) and IRF1 (interferon regulatory factor 1). IL6ST overexpression was shown to inhibit adipogenesis by affecting Ras/STAT (signal transducer and activator of transcription) signaling, 35 and IRFs have key roles in immune response, but they have been recently also identified as inhibitors of adipogenesis. 36 Morphological changes, when the fibroblast-like shape changes into a spherical shape, mostly occur in the first 12 h of differentiation and are associated with ECM and cytoskeletal changes. 31, 37 A number of genes encoding ECM and cytoskeletal constituents showed altered expression in T2DM preadipocytes, like decreased expression of collagens, integrins, actins and tropomyosins, and an increment of fibronectin ( Figure 3 and Table 4 ). ECM and cytoskeletal modifiers like matrix metallopeptidase 1 (MMP1), matrix metallopeptidase 2 (MMP2) and a desintegrin and metallopeptidase domain 12 (ADAM12) were also downregulated in T2DM preadipocytes; only ADAMTS5 (ADAM metallopeptidase with thrombospondin type 1 motif 5) was upregulated in T2DM preadipocytes, but its exact function in adipogenesis is still unknown. Taken together, the expression profile of T2DM preadipocytes suggests a decreased differentiation capacity. This is in line with previous studies that showed decreased expression of key adipogenesis regulators that are induced after induction Intrinsic gene expression changed in T2DM preadipocytes FHJ van Tienen et al of adipogenesis, for example, PPARg, C/EBPb and SREBP1, and a reduced formation of new adipocytes in T2DM subjects and mouse models. [38] [39] [40] Additionally, the importance of insulin signaling in adipogenesis is exemplified by the fact that expression of cytoskeleton, adhesion and ECM components is upregulated by insulin treatment of mouse 3T3-L1 preadipocytes. [41] [42] [43] Previous studies have suggested that decreased adipogenesis in diabetic subjects could be a result of altered adipokine signaling or inflammatory cytokines. 44 This cannot be observed in our data as those studies were conducted on adipose tissue or isolated adipocytes, whereas our study focused on cultured preadipocytes, which allowed us to detect intrinsic changes leading to decreased adipogenesis capacity. Whether this is the consequence of insulin resistance in T2DM due to altered signaling of macrophages and adipocytes, or that decreased differentiation capacity predisposes to it, is yet unclear. In contrast to the general downregulation of the adipogenesis process, the expressions of genes involved in adipogenesis, which are stimulated by inflammation, were upregulated in T2DM preadipocytes. This shows that adipogenesis involves multiple regulators, and the relative effect of the regulators has to be studied more closely to determine key regulators that might define disease progression.
Lipid metabolism
Expression of genes that have a role in lipid metabolism, including lipid b-oxidation, HSL-stimulated lipolysis and lipogenesis, were downregulated in T2DM preadipocytes. CPT1a expression was downregulated in T2DM patients, but did not result in a reduced CPT1 activity, indicating that the reduced expression does not affect lipid import into mitochondria for b-oxidation. As CPT1a is first upregulated at the induction of adipogenesis and then expression switches from mainly CPT1a toward expression of both CPT1a and CPT1b (Figure 2) , 45 the reduced expression of CPT1a in T2DM preadipocytes could be involved in preadipocyte differentiation rather than metabolism in preadipocytes. The reduced expression of genes involved in HSL-mediated lipolysis is in agreement with previous reports in insulin-resistant preadipocytes and adipocytes. 46 However, as preadipocytes are not metabolically very active, the effect of reduced lipolysis can also be a consequence of decreased expression of key regulators of adipogenesis in T2DM, like PPARg and SREBP1. These intrinsic changes in T2DM preadipocyte lipid metabolism might therefore contribute to the altered adipogenesis process, but it could also have an effect on the metabolism of fully differentiated adipocytes.
Inflammation and apoptosis
The processes associated with complement and caspase activation and regulation of apoptosis/programmed cell death were over-represented in T2DM preadipocytes.
Antiapoptotic gene expression was decreased and proapoptotic gene expression was increased. Inflammation-related gene expression has been observed in adipocytes and preadipocytes from obese Pima Indians when compared with non-obese Pima Indians. 13, 16 Inflammation is regarded as a general characteristic of obesity, but gene expression analysis suggests a tendency to enhanced apoptosis in preadipocytes of T2DM subjects. However, no significant change in growth of the T2DM preadipocytes were observed due to enhanced apoptosis. Furthermore, accurate experiments, like apoptosis assays and growth curves, should clarify the role and significance of apoptosis in preadipocytes of T2DM patients.
In conclusion, several molecular pathways are altered in cultured T2DM preadipocytes, providing a first comprehensive overview of the molecular processes involved. This gives a possible explanation for the decreased formation of new adipocytes, and enlarged adipocytes in patients with T2DM, which contribute to increased ectopic fat deposition. Additionally, we have demonstrated that these alterations are not because of signaling from other cell types. Gaining insight in the molecular mechanism of adipogenesis may lead to identification of targets for therapeutic interventions, aiming at enhancing adipocyte differentiation and metabolism to improve lipid storage capacity, which in consequence could reduce ectopic fat depositioning and enhance insulin sensitivity.
